MedElevator
Войти в исследования Meta-analyses of randomised trials: when the whole is more than just the sum of the parts.
Аннотация
Аннотация не предоставлена источником. Содержательный обзор этой публикации недоступен.
Перевод полного текста: Перевод в очереди
Полный текст источника
This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/ .
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
Begg C. B., Engstrom P. F. Eligibility and extrapolation in cancer clinical trials. J Clin Oncol. 1987 Jun;5(6):962–968. doi: 10.1200/JCO.1987.5.6.962.
Bobbio M., Demichelis B., Giustetto G. Completeness of reporting trial results: effect on physicians' willingness to prescribe. Lancet. 1994 May 14;343(8907):1209–1211. doi: 10.1016/s0140-6736(94)92407-4.
DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986 Sep;7(3):177–188. doi: 10.1016/0197-2456(86)90046-2.
Dickersin K., Scherer R., Lefebvre C. Identifying relevant studies for systematic reviews. BMJ. 1994 Nov 12;309(6964):1286–1291. doi: 10.1136/bmj.309.6964.1286.
Gray R., James R., Mossman J., Stenning S. AXIS--a suitable case for treatment. UK Coordinating Committee on Cancer Research (UKCCCR) Colorectal Cancer Subcommittee. Br J Cancer. 1991 Jun;63(6):841–845. doi: 10.1038/bjc.1991.187.
Gregory W. M., Richards M. A., Malpas J. S. Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials. J Clin Oncol. 1992 Feb;10(2):334–342. doi: 10.1200/JCO.1992.10.2.334.
Gøtzsche P. C. Reference bias in reports of drug trials. Br Med J (Clin Res Ed) 1987 Sep 12;295(6599):654–656.
Himel H. N., Liberati A., Gelber R. D., Chalmers T. C. Adjuvant chemotherapy for breast cancer. A pooled estimate based on published randomized control trials. JAMA. 1986 Sep 5;256(9):1148–1159. doi: 10.1001/jama.256.9.1148.
King J. F., Grant A., Keirse M. J., Chalmers I. Beta-mimetics in preterm labour: an overview of the randomized controlled trials. Br J Obstet Gynaecol. 1988 Mar;95(3):211–222. doi: 10.1111/j.1471-0528.1988.tb06860.x.
Peto R. Why do we need systematic overviews of randomized trials? Stat Med. 1987 Apr-May;6(3):233–244. doi: 10.1002/sim.4780060306.
Pignon J. P., Arriagada R., Ihde D. C., Johnson D. H., Perry M. C., Souhami R. L., Brodin O., Joss R. A., Kies M. S., Lebeau B. A meta-analysis of thoracic radiotherapy for small-cell lung cancer. N Engl J Med. 1992 Dec 3;327(23):1618–1624. doi: 10.1056/NEJM199212033272302.
Simon R., Altman D. G. Statistical aspects of prognostic factor studies in oncology. Br J Cancer. 1994 Jun;69(6):979–985. doi: 10.1038/bjc.1994.192.
Simon R. The role of overviews in cancer therapeutics. Stat Med. 1987 Apr-May;6(3):389–396. doi: 10.1002/sim.4780060335.
Slevin M. L., Stubbs L., Plant H. J., Wilson P., Gregory W. M., Armes P. J., Downer S. M. Attitudes to chemotherapy: comparing views of patients with cancer with those of doctors, nurses, and general public. BMJ. 1990 Jun 2;300(6737):1458–1460. doi: 10.1136/bmj.300.6737.1458.
Stewart L. A., Clarke M. J. Practical methodology of meta-analyses (overviews) using updated individual patient data. Cochrane Working Group. Stat Med. 1995 Oct 15;14(19):2057–2079. doi: 10.1002/sim.4780141902.
Stewart L. A., Parmar M. K. Meta-analysis of the literature or of individual patient data: is there a difference? Lancet. 1993 Feb 13;341(8842):418–422. doi: 10.1016/0140-6736(93)93004-k.
Thompson S. G. Why sources of heterogeneity in meta-analysis should be investigated. BMJ. 1994 Nov 19;309(6965):1351–1355. doi: 10.1136/bmj.309.6965.1351.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.